淋巴瘤的放射免疫治疗进展
被引量：1
Progress in Radioimmunotherapy for Lymphoma
摘要
放射免疫治疗是众多免疫靶向治疗的一种,在恶性肿瘤的治疗中具有独到的优势,目前主要应用于血液系统肿瘤,尤其是淋巴瘤。文章就近年来淋巴瘤放射免疫治疗的最新进展作一综述。
出处
《中国肿瘤》
CAS
2010年第3期184-189,共6页
China Cancer
参考文献28
-
1Kroger LA, Denardo GL, Gumerlock PH, et al. Apoptosis-related gene and protein expression in human lymphoma xenografts(Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy [J]. Cancer Biother Radiopharm, 2001, 16(3):213-225.
-
2Couturier O, Faivre Chauvet A, Filippovich IV, et al. Validation of ^213Bi-alpha radioimmunotherapy for muhiple myeloma [J]. Clin Cancer Res, 1999, 5 (10 Suppl):3165s- 3170s.
-
3Denardo SJ, Kukis DL, Miers LA, et al. Yttrium-90-DOTA-peptidechimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing P53 mutant human breast cancer xenografts [J]. J Nucl Med, 1998, 39(5):842-849.
-
4Kaminski MS, Zasadny KR, Francis IR, et al. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma [J].J Clin Oncol, 1996, 14 (7):1974-1981.
-
5Wiseman GA, White CA, Sparks RB, et al. Biodistribution and dosimetry results from a phase Ⅲ prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell nonHodgkin's lymphoma [J]. Crit Rev Oncol Hematol, 2001, 39 (1-2): 181-194.
-
6Hnatowich D J, Chinol DA, Siebicker M, et al. Patient biodistribution of intraperitoneally administered yttrium-90-1abeled antibody[J]. J Nucl Med, 1988, 29(8): 1428-1435.
-
7Hubalewska-Dydejczyk A, Jurczak W, Sowa-Staszczak A, et al. New forms of radionuclide therapy with (90)Y in oncology [J]. Nucl Med Rev Cent East Eur, 2008, 11(1):5- 11.
-
8Ferrucci PF, Vanazzi A, Grana CM, et al. High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas [J]. Br J Haematol, 2007, 139(4):590-599.
-
9Kaminski Ms, Zassadny KR, Francis IR, et al. Radioimmunotherapy of B-cell lymphoma with[131I]antiB1(anti-CD20)antibody[J]. N Engl J Med, 1993, 329(7):459-465.
-
10Kaminski Ms, Estes J, Zasadny KR, et al. Radioimmunotherapy with iodine (131) tositumomab for relapsed or refractory B-cell non- Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience [J]. Blood, 2000, 96(4):1259-1266.
同被引文献9
-
1周凤智,张国楠,孙维刚,宋水勤,樊英.女性生殖系统原发性恶性淋巴瘤9例临床分析[J].中国妇产科临床杂志,2005,6(6):409-412. 被引量：13
-
2方蓉,陈映霞,秦叔逵,钱军,王琳.原发性卵巢恶性淋巴瘤2例报告及文献复习[J].临床肿瘤学杂志,2006,11(1):61-62. 被引量：1
-
3YILDIRIM Y. Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with L, low dose Methotrexate[J]. Gynecologic Oncol, 2005,97 : 249-- 252.
-
4LANJEWAR D N,DONGAONKAR D D.HIV-associated primary non-Hodgkin's lymphoma of ovary:A case report[J].Gynecologic Oncol,2006,102:590-592.
-
5FOX H,LANGLEY F A,GOVAN A D T,et al.Malignant lymphoma presenting as an ovarian tumor:a clinicopathological analysis of 34 cases[J].Br J Obstet Gynaecol,1988,95:386-390.
-
6AMBULKAR I,NAIR R.Primary ovarian lymphoma:report of cases and review of literature[J].Leuk Lymphoma,2003,44:825-825.
-
7KENDRICK J E,MICHAEL STRAUGHN J.Two cases of non-Hodgkin's lymphoma presenting as primary gynecologic malignancies[J].Gynecologic Oncol,2005,98:490-492.
-
8牛伶.美罗华联合化疗治疗B细胞性非霍奇金淋巴瘤11例[J].临床血液学杂志,2009,22(4):385-386. 被引量：5
-
9颜笑健,梁立治,熊樱.8例卵巢非霍奇金淋巴瘤临床分析[J].肿瘤学杂志,2001,7(4):236-238. 被引量：5
二级引证文献5
-
1吴建磊,接智慧,史春雪,常爽,王敏.原发性卵巢非霍奇金淋巴瘤32例临床分析[J].中国实用妇科与产科杂志,2013,29(5):359-363. 被引量：5
-
2陶自坚.卵巢原发性恶性淋巴瘤(附一例报告)[J].现代医学,2014,42(9):1091-1094.
-
3沈艳,王方.女性生殖系统淋巴瘤的超声表现和病理特征分析[J].中国性科学,2015,24(10):27-29.
-
4顾凯月,任颖.原发性女性生殖系统淋巴瘤的诊治进展[J].临床与实验病理学杂志,2021,37(2):195-198. 被引量：3
-
5龙英丽,宋灿.原发性卵巢伯基特淋巴瘤研究进展[J].中国基层医药,2022,29(8):1271-1275.
-
1胡嘏,王少刚.膀胱肿瘤实验研究的现状与展望[J].中华实验外科杂志,2016,33(6):1440-1443. 被引量：5
-
2张柳琴,施敏骅.免疫靶向治疗在非小细胞肺癌中的研究进展[J].国际呼吸杂志,2016,0(4):304-308. 被引量：3
-
3罗以.局部晚期/远处转移的头颈部鳞癌的诊治策略[J].肿瘤药学,2016,6(1):1-3. 被引量：6
-
4张丙忠,王静,张莘,沙孝珍,谭玉婷,林仲秋,陈勍.^(131)Ⅰ标记的抗c-erbB-2单克隆抗体免疫靶向治疗卵巢癌的实验研究[J].中华妇产科杂志,2004,39(12):833-835.
-
5李明浩,贾瑞鹏.PSMA特异性CAR-T在前列腺癌免疫治疗中的研究进展[J].国际泌尿系统杂志,2016,0(1):37-39.
-
6姚尔固.白血病的靶向治疗[J].白血病．淋巴瘤,2005,14(1):41-42. 被引量：2
-
7徐妍,刘加军,许崇艳.黏蛋白1的结构、功能以及与血液恶性肿瘤关系的研究进展[J].新医学,2008,39(11):758-759.
-
8李尤,华海清.肝癌分子靶向药物的研究进展[J].临床肿瘤学杂志,2016,21(5):462-468. 被引量：4
-
9雷泽民,余宗阳.非小细胞肺癌T细胞PD-1免疫靶向治疗研究现状与展望[J].中国肿瘤,2015,24(5):398-402. 被引量：15
-
10邓圆圆,范益民.Tim-3在肿瘤免疫中的研究进展[J].中华神经创伤外科电子杂志,2016,2(2):112-115. 被引量：8
